| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.37B | 49.82B | 42.11B | 42.72B | 43.09B | 46.44B |
| Gross Profit | 11.47B | 11.62B | 7.35B | 7.81B | 8.67B | 7.94B |
| EBITDA | 7.31B | 7.58B | 4.48B | 6.35B | 7.26B | 5.74B |
| Net Income | 3.73B | 3.97B | 1.64B | 2.86B | 3.91B | 2.16B |
Balance Sheet | ||||||
| Total Assets | 69.02B | 71.74B | 68.82B | 67.66B | 68.69B | 67.26B |
| Cash, Cash Equivalents and Short-Term Investments | 14.95B | 16.96B | 18.16B | 20.65B | 18.38B | 14.46B |
| Total Debt | 8.97B | 10.23B | 10.89B | 10.24B | 9.09B | 8.22B |
| Total Liabilities | 22.23B | 23.18B | 22.57B | 20.55B | 20.72B | 19.81B |
| Stockholders Equity | 46.78B | 48.56B | 46.25B | 47.11B | 47.94B | 46.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.34B | -559.77M | -904.26M | 3.89B | -1.37B |
| Operating Cash Flow | 0.00 | 4.55B | 3.22B | 3.47B | 5.90B | 610.51M |
| Investing Cash Flow | 0.00 | -2.08B | -1.06B | 508.63M | 2.87B | 1.57B |
| Financing Cash Flow | 0.00 | -4.09B | -3.42B | -2.57B | -4.04B | -5.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥446.06B | 9.19 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | $755.37B | 25.94 | 8.09% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥88.09B | 22.30 | ― | 5.68% | 8.00% | 6.44% | |
74 Outperform | ¥79.61B | 38.22 | ― | 2.20% | 4.75% | 164.54% | |
70 Outperform | ¥89.27B | 23.76 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | $184.08B | 24.55 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |